Assessment of pneumonia severity: a European perspective
Open Access
- 1 January 2006
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 27 (1) , 6-8
- https://doi.org/10.1183/09031936.06.00130205
Abstract
In 1997, Fine et al. 6 introduced the pneumonia severity index (PSI). The PSI consists of 20 variables reflecting age, sex, residence, comorbidity and acute pneumonia-associated morbidity. These variables were derived from and validated in >50,000 patients, the largest database ever studied in the history of pneumonia research. The original role of the PSI was to identify those patients at a low risk of mortality who, therefore, could safely be treated as outpatients. Three risk classes were identified with a very low-risk 30-day mortality of 1–3%, a fourth with an increased risk of ∼8%, and a fifth with a high risk of ∼30%. The PSI was subsequently confirmed to make valid predictions of mortality by several authors, although in some reports mortality rates were somewhat lower in the highest risk group 7–9. Finally, the PSI was also shown to predict long-term outcomes of CAP 10. A major limitation of the PSI is the unbalanced impact of age on the score, resulting in a potential underestimation of severe pneumonia, particularly in younger otherwise healthy individuals 9. Nevertheless, the PSI is currently recommended as a tool of severity assessment in the Infectious Diseases Society of America guidelines 2, 3.Keywords
This publication has 19 references indexed in Scilit:
- Validation of a predictive rule for the management of community-acquired pneumoniaEuropean Respiratory Journal, 2006
- Guidelines for the management of adult lower respiratory tract infectionsEuropean Respiratory Journal, 2005
- Validation of predictive rules and indices of severity for community acquired pneumoniaThorax, 2004
- Assessment of Mortality after Long-Term Follow-Up of Patients with Community-Acquired PneumoniaClinical Infectious Diseases, 2003
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community‐Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission CriteriaClinical Infectious Diseases, 2001
- Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic SocietyClinical Infectious Diseases, 2000
- Severity prediction rules in community acquired pneumonia: a validation studyThorax, 2000
- An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory Society.Thorax, 1996
- Community acquired pneumonia: aetiology and prognostic index evaluation.Thorax, 1991